{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:37:19Z","timestamp":1722559039732},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.7759\/cureus.65894","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T03:57:51Z","timestamp":1722484671000},"source":"Crossref","is-referenced-by-count":0,"title":["Investigating the Use of 0.3% Adapalene\/2.5% Benzoyl Peroxide Gel for the Management of Moderate-to-Severe Acne in Indian Patients: A Phase 4 Study Assessing Safety and Efficacy"],"prefix":"10.7759","author":[{"given":"Rohit","family":"Batra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Yogendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudarshan","family":"Gaurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyotona","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Jadhwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global Health Metrics. Acne vulgaris\u2014Level 3 cause. (2024). Accessed: January 04, 2024: https:\/\/www.thelancet.com\/pb-assets\/Lancet\/gbd\/summaries\/diseases\/acne-vulgaris.pdf."},{"key":"ref2","article-title":"Acne Vulgaris","author":"Sutaria AH","year":"2024","unstructured":"Sutaria AH, Masood S, Saleh HM, Schlessinger J. Acne Vulgaris. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101578","article-title":"Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances","volume":"36","author":"Vasam M","year":"2023","unstructured":"Vasam M, Korutla S, Bohara RA. Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023, 36:101578. 10.1016\/j.bbrep.2023.101578","journal-title":"Biochem Biophys Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein AL","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, et al.. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016, 74:945-73.e33. 10.1016\/j.jaad.2015.12.037","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2022.4275","article-title":"Adapalene\/benzoyl peroxide gel 0.3%\/2.5% for acne vulgaris","volume":"32","author":"Dr\u00e9no B","year":"2022","unstructured":"Dr\u00e9no B, Layton AM, Troielli P, Rocha M, Chavda R. Adapalene\/benzoyl peroxide gel 0.3%\/2.5% for acne vulgaris. Eur J Dermatol. 2022, 32:445-50. 10.1684\/ejd.2022.4275","journal-title":"Eur J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011154.pub2","article-title":"Topical benzoyl peroxide for acne","volume":"3","author":"Yang Z","year":"2020","unstructured":"Yang Z, Zhang Y, Lazic Mosler E, et al.. Topical benzoyl peroxide for acne. Cochrane Database Syst Rev. 2020, 3:CD011154. 10.1002\/14651858.CD011154.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","unstructured":"Central Drugs Standard Control Organisation. New drugs approved by CDSCO. (2024). Accessed: January 09, 2024: https:\/\/cdscoonline.gov.in\/CDSCO\/Drugs."},{"key":"ref8","article-title":"Adapalene","author":"Tolaymat L","year":"2024","unstructured":"Tolaymat L, Dearborn H, Zito PM. Adapalene. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00423-z","article-title":"Topical retinoids in acne vulgaris: a systematic review","volume":"20","author":"Kolli SS","year":"2019","unstructured":"Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol. 2019, 20:345-65. 10.1007\/s40257-019-00423-z","journal-title":"Am J Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13194","article-title":"Safety and efficacy of adapalene 0.1% \/ benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG","volume":"29 Suppl 4","author":"Gollnick HP","year":"2015","unstructured":"Gollnick HP, Friedrich M, Peschen M, et al.. Safety and efficacy of adapalene 0.1% \/ benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG. J Eur Acad Dermatol Venereol. 2015, 29 Suppl 4:15-22. 10.1111\/jdv.13194","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref11","article-title":"Customized single-agent therapy management of severe inflammatory acne: a randomized, double-blind, parallel-group, controlled study of a new treatment--adapalene 0.3%-benzoyl peroxide 2.5% gel","volume":"14","author":"Weiss J","year":"2015","unstructured":"Weiss J, Stein Gold L, Leoni M, Rueda MJ, Liu H, Tanghetti E. Customized single-agent therapy management of severe inflammatory acne: a randomized, double-blind, parallel-group, controlled study of a new treatment--adapalene 0.3%-benzoyl peroxide 2.5% gel. J Drugs Dermatol. 2015, 14:1427-35.","journal-title":"J Drugs Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0352-y","article-title":"Prevention and reduction of atrophic acne scars with adapalene 0.3%\/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison","volume":"19","author":"Dr\u00e9no B","year":"2018","unstructured":"Dr\u00e9no B, Bissonnette R, Gagn\u00e9-Henley A, Barankin B, Lynde C, Kerrouche N, Tan J. Prevention and reduction of atrophic acne scars with adapalene 0.3%\/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison. Am J Clin Dermatol. 2018, 19:275-86. 10.1007\/s40257-018-0352-y","journal-title":"Am J Clin Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00454-6","article-title":"Long-term effectiveness and safety of up to 48 weeks' treatment with topical adapalene 0.3%\/benzoyl peroxide 2.5% gel in the prevention and reduction of atrophic acne scars in moderate and severe facial acne","volume":"20","author":"Dr\u00e9no B","year":"2019","unstructured":"Dr\u00e9no B, Bissonnette R, Gagn\u00e9-Henley A, et al.. Long-term effectiveness and safety of up to 48 weeks' treatment with topical adapalene 0.3%\/benzoyl peroxide 2.5% gel in the prevention and reduction of atrophic acne scars in moderate and severe facial acne. Am J Clin Dermatol. 2019, 20:725-32. 10.1007\/s40257-019-00454-6","journal-title":"Am J Clin Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.481","article-title":"Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel","volume":"138","author":"Bershad S","year":"2002","unstructured":"Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW, Persaud AN, Lebwohl M. Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol. 2002, 138:481-9. 10.1001\/archderm.138.4.481","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3126\/nmj.v5i2.47237","article-title":"Effect of application, duration and dosing frequency on the efficacy and adverse effect of adapalene in acne vulgaris: an open-label randomized controlled study","volume":"5","author":"Jha PK","year":"2022","unstructured":"Jha PK, Singh SK, Rai T. Effect of application, duration and dosing frequency on the efficacy and adverse effect of adapalene in acne vulgaris: an open-label randomized controlled study. Nepal Med J. 2022, 5:589-96. 10.3126\/nmj.v5i2.47237","journal-title":"Nepal Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.36849\/jdd.6259","article-title":"Recommendations for using over-the-counter products as adjunctive acne care in Asian phototypes: improving treatment outcomes and managing side effects","volume":"20","author":"Andriessen A","year":"2021","unstructured":"Andriessen A, Jiang X, Kulthanan K, Lee CH, Sinclair R, Zhang CF. Recommendations for using over-the-counter products as adjunctive acne care in Asian phototypes: improving treatment outcomes and managing side effects. J Drugs Dermatol. 2021, 20:1213-21. 10.36849\/jdd.6259","journal-title":"J Drugs Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2012.661037","article-title":"Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects","volume":"24","author":"Matsunaga K","year":"2013","unstructured":"Matsunaga K, Leow YH, Chan R, Kerrouche N, Paliargues F. Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects. J Dermatolog Treat. 2013, 24:278-82. 10.3109\/09546634.2012.661037","journal-title":"J Dermatolog Treat"},{"key":"ref18","article-title":"A comparative study of efficacy and tolerability of topical benzoyl peroxide versus topical benzoyl peroxide with adapalene in mild to moderate acne","volume":"85","author":"Geetha A","year":"2023","unstructured":"Geetha A, Vishaka, Raghav MV, Asha GS. A comparative study of efficacy and tolerability of topical benzoyl peroxide versus topical benzoyl peroxide with adapalene in mild to moderate acne. Indian J Pharm Sci. 2023, 85:1534-8.","journal-title":"Indian J Pharm Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/ijdd.ijdd_29_20","article-title":"Topical 0.1% adapalene gel versus 0.1% adapalene and 2.5% benzoyl peroxide combination gel in the treatment of mild-to-moderate acne vulgaris: an open-label randomized controlled pilot study","volume":"7","author":"Amrutha M","year":"2021","unstructured":"Amrutha M, Bifi J, Anoop T, Ajayakumar S, Radhakrishnan K, Rajiv S. Topical 0.1% adapalene gel versus 0.1% adapalene and 2.5% benzoyl peroxide combination gel in the treatment of mild-to-moderate acne vulgaris: an open-label randomized controlled pilot study. Indian J Drugs Dermatol. 2021, 7:20-3. 10.4103\/ijdd.ijdd_29_20","journal-title":"Indian J Drugs Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0178-4","article-title":"Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3\u00a0%\/benzoyl peroxide 2.5\u00a0% gel: a randomized, double-blind, parallel-group, controlled study","volume":"17","author":"Stein Gold L","year":"2016","unstructured":"Stein Gold L, Weiss J, Rueda MJ, Liu H, Tanghetti E. Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3\u00a0%\/benzoyl peroxide 2.5\u00a0% gel: a randomized, double-blind, parallel-group, controlled study. Am J Clin Dermatol. 2016, 17:293-303. 10.1007\/s40257-016-0178-4","journal-title":"Am J Clin Dermatol"},{"key":"ref21","article-title":"Adapalene\/Benzoyl peroxide gel 0.3%\/2.5%: effective acne therapy regardless of age or gender","volume":"16","author":"Stein Gold L","year":"2017","unstructured":"Stein Gold L, Werschler WP, Mohawk J. Adapalene\/Benzoyl peroxide gel 0.3%\/2.5%: effective acne therapy regardless of age or gender. J Drugs Dermatol. 2017, 16:582-9.","journal-title":"J Drugs Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260272-investigating-the-use-of-03-adapalene25-benzoyl-peroxide-gel-for-the-management-of-moderate-to-severe-acne-in-indian-patients-a-phase-4-study-assessing-safety-and-efficacy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T03:58:00Z","timestamp":1722484680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260272-investigating-the-use-of-03-adapalene25-benzoyl-peroxide-gel-for-the-management-of-moderate-to-severe-acne-in-indian-patients-a-phase-4-study-assessing-safety-and-efficacy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.65894","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}